ReceptorPharma

Receptor Pharma

Biotechnology, 838 Walker Rd, Dover, Delaware, 19904, United States, 1-10 Employees

receptorpharma.com

  • twitter
  • LinkedIn

Who is RECEPTORPHARMA

ReceptorPharma has the goal to develop new Alzheimers drugs through a completely new pathway and mechanism. We are utilizing the very latest research and findings regarding disease-couple...

Read More

map
  • 838 Walker Rd, Dover, Delaware, 19904, United States Headquarters: 838 Walker Rd, Dover, Delaware, 19904, United States
  • 2017 Date Founded: 2017
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from RECEPTORPHARMA

ReceptorPharma Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding ReceptorPharma

Answer: ReceptorPharma's headquarters are located at 838 Walker Rd, Dover, Delaware, 19904, United States

Answer: ReceptorPharma's official website is https://receptorpharma.com

Answer: ReceptorPharma's revenue is Under $1 Million

Answer: ReceptorPharma's SIC: 2834

Answer: ReceptorPharma's NAICS: 325412

Answer: ReceptorPharma has 1-10 employees

Answer: ReceptorPharma is in Biotechnology

Answer: ReceptorPharma contact info: Phone number: Website: https://receptorpharma.com

Answer: ReceptorPharma has the goal to develop new Alzheimers drugs through a completely new pathway and mechanism. We are utilizing the very latest research and findings regarding disease-coupled genes and combining it with the usage of one of the most well-studied drug target protein families. This novel approach to create a new generation of Alzheimers disease drugs that act through is our competitive advantage and where our competences shine. In addition to Alzheimers disease, our approach will allow for the development of new drugs for several additional debilitating diseases, including certain types of cancer, through similar mechanisms using disease-coupled as drug targets.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access